Inventor · disambiguated record
Michel Demeule
Also filed as: DEMEULE MICHEL
21 granted patents·32 pending applications·174 citations·filing 2002–2025
95Inventor score
Top patents by PatentIndex Score
53 records- 0195US7700554B2Compositions for modulating blood-brain barrier transportRAPTOR PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·44 cites·2 claims
- 0294US7557182B2Molecules for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2005·Granted Jul 7, 2009·37 cites·28 claims
- 0392US11780882B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2021·Granted Oct 10, 2023·3 cites·21 claims
- 0492US7902156B2Aprotinin polypeptides for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2005·Granted Mar 8, 2011·21 cites·14 claims
- 0590US12269902B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2023·Granted Apr 8, 2025·1 cites·20 claims
- 0688US11034727B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2016·Granted Jun 15, 2021·6 cites·26 claims
- 0783US8969310B2Potentiation of anticancer agentsBELIVEAU RICHARD·Filed 2007·Granted Mar 3, 2015·6 cites·11 claims
- 0883US8828925B2Etoposide and doxorubicin conjugates for drug deliveryDEMEULE MICHEL·Filed 2009·Granted Sep 9, 2014·6 cites·7 claims
- 0983US8487072B2Compounds for stimulating P-glycoprotein function and uses thereofBELIVEAU RICHARD·Filed 2007·Granted Jul 16, 2013·12 cites·4 claims
- 1080US7977317B2Compositions and methods for modulating blood-brain barrier transportRAPTOR PHARMACEUTICAL INC·Filed 2010·Granted Jul 12, 2011·4 cites·9 claims
- 1179US9173891B2Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analogCASTAIGNE JEAN-PAUL·Filed 2010·Granted Nov 3, 2015·6 cites·16 claims
- 1278US8921314B2Conjugates of GLP-1 agonists and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Granted Dec 30, 2014·5 cites·8 claims
- 1377US9161988B2Multimeric peptide conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2010·Granted Oct 20, 2015·6 cites·14 claims
- 1477US8710013B2Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and useDEMEULE MICHEL·Filed 2009·Granted Apr 29, 2014·5 cites·31 claims
- 1572US2025296957A1Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2025·Application pending·0 cites
- 1671US8828949B2Aprotinin polypeptides for transporting a compound across the blood-brain barrierBELIVEAU RICHARD·Filed 2011·Granted Sep 9, 2014·1 cites·37 claims
- 1770US9713646B2Potentiation of anticancer agentsANGIOCHEM INC·Filed 2015·Granted Jul 25, 2017·1 cites·19 claims
- 1865US9687561B2Peptide-dendrimer conjugates and uses thereofANGIOCHEM INC·Filed 2013·Granted Jun 27, 2017·1 cites·19 claims
- 1965US7919103B2Compound and method for regulating plasminogen activation and cell migrationTRANSFERT PLUS·Filed 2004·Granted Apr 5, 2011·6 cites·7 claims
- 2064US9221867B2Method for transporting a compound across the blood-brain barrierBéLIVEAU RICHARD·Filed 2004·Granted Dec 29, 2015·3 cites·20 claims
- 2160US2015174266A1Aprotinin polypeptides for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 2258US2016106856A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 2357US9914754B2Conjugates of neurotensin or neurotensin analogs and uses thereofCASTAIGNE JEAN PAUL·Filed 2009·Granted Mar 13, 2018·0 cites·25 claims
- 2457US2011288011A1Peptide therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 2556US2015038429A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 2655US9365634B2Aprotinin-like polypeptides for delivering agents conjugated thereto to tissuesBéLIVEAU RICHARD·Filed 2008·Granted Jun 14, 2016·0 cites·13 claims
- 2755US2024156971A1Methods and sortilin binding conjugate compounds for targeting cancer stem cellsTRANSFERT PLUS SOC EN COMMANDITE·Filed 2022·Application pending·0 cites
- 2854US2009016959A1Delivery of antibodies to the central nervous systemBELIVEAU RICHARD·Filed 2007·Application pending·0 cites
- 2952US2018221497A1Potentiation of anticancer agentsANGIOCHEM INC·Filed 2017·Application pending·0 cites
- 3052US2017281787A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 3150US2023036041A1Sortilin binding conjugate compounds, compositions and uses thereof for treating cancerTHERATECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 3250US2003129186A1Compositions and methods for modulating blood-brain barrier transportBIOMARIN PHARM INC·Filed 2002·Application pending·0 cites
- 3349US2011039785A1Polypeptide-nucleic acid conjugates and uses thereofANGIOCHEM INC·Filed 2008·Application pending·0 cites
- 3449US2016375145A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 3547US2017080100A1Delivery of antibodies to the central nervous systemANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 3646US2011288009A1Leptin and leptin analog conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 3746US2022000971A1Methods and compounds for targeting sortilin receptors and inhibiting vasculogenic mimicryTRANSFERT PLUS SEC·Filed 2019·Application pending·0 cites
- 3846US2016367691A1Targeted enzyme compounds and uses thereofANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 3945US2018015180A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2017·Application pending·0 cites
- 4042US2012277158A1Compositions and methods for the transport of therapeutic agentsCASTAIGNE JEAN-PAUL·Filed 2010·Application pending·0 cites
- 4141US2011243952A1Compound and method for regulating plasminogen activation and cell migrationTRANSFERT PLUS·Filed 2011·Application pending·0 cites
- 4241US2016263236A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 4341US2015290341A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 4440US2016213760A1Aprotinin-derived polypeptide-antibody conjugatesANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 4539US2015174267A1Compositions and methods for the transport of therapeutic agentsANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 4637US2016263235A1Peptide therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 4736US2013280281A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2011·Application pending·0 cites
- 4836US2020157151A1Peptide compounds, conjugate compounds and uses thereof for treating inflammatory diseasesTRANSFERT PLUS SEC·Filed 2018·Application pending·0 cites
- 4936US2017326233A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 5035US2014335163A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →